anastrozole


Also found in: Medical, Wikipedia.
Related to anastrozole: tamoxifen

anastrozole

(əˈnæstrəˌzəʊl)
n
(Pharmacology) an anti-oestrogen drug used in the treatment of breast cancer in post-menopausal women. Also called: Arimidex
Translations

anastrozole

n anastrozol m
Mentioned in ?
References in periodicals archive ?
Objective: To evaluate the effects of prolonged use of anastrozole as an endocrine treatment of breast cancer on the lens in an animal model.
Reportedly, this EU approval is based on pivotal data from the Phase III FALCON trial, which demonstrated the superiority of Faslodex 500mg over anastrozole 1mg as a first -line treatment for postmenopausal women with locally-advanced or HR+ metastatic breast cancer who had not received prior hormone-based therapy.
The EU approval is based on pivotal data from the Phase III FALCON trial, which demonstrated the superiority of Faslodex 500mg over anastrozole 1mg as a first-line treatment for postmenopausal women with locally-advanced or HR+ metastatic breast cancer who had not received prior hormone-based therapy.
Aromatase inhibitors, which include anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara), were taken by 26 percent of the women for an average of 2.
AS PART OF ITS NEW WOMEN'S WELLNESS INITIATIVE, representatives of Schnucks Pharmacies have made four different oral breast cancer medications (Letrozole, Megestrol, Anastrozole and Tamoxifen) available for only $9 with a prescription.
In a randomized trial of letrozole versus anastrozole for ovulation induction, 40 women with PCOS were randomly assigned to receive ovulation induction with letrozole (2.
Two illegal substances surfaced in his test, Anastrozole and Clomiphene which are both on the World Anti-Doping Agency's 2014 prohibited list, for in-competition and out-of-competition use.
Anastrozole has been found to reduce the likelihood of breast cancer by 53% among women who are at higher risk of the disease.
About half the women took anastrozole for five years, while the others took a placebo.
13 ( ANI ): A new study has shown that taking the breast cancer drug anastrozole for five years reduces the chances of developing the disease in high risk post-menopausal women by 53 percent compared with women who took a placebo.
Cancer Research UK's crucial work in the laboratory is behind many important drugs, such as tamoxifen and herceptin, and our trials of drugs called aromatase inhibitors paved the way for the development of anastrozole - all of this is helping to give women with breast cancer more treatment options.
The scientists concluded that, "The combination of anastrozole and fulvestrant was superior to anastrozole alone or sequential anastrozole and fulvestrant for the treatment of HR-positive metastatic breast cancer, despite the use of a dose of fulvestrant that was below the current standard.